STAT stories you may have missed 

Long-time biotech rivals Alnylam and Dicerna are announcing a ceasefire. 

This biotech is stopping a Phase 3 trial early because the results are so strong. 

STAT chatted with Siddhartha Mukherjee about his new film with Ken Burns. Read the full interview here. 

Large employers could have saved $1.5 million if they pushed biosimilars, a new study finds. 

Opinion: If we can verify people who’ve already recovered from Covid-19, they could help jump-start the economy by working in health care, transportation, retail, and more.

As the country prepares for a possible recession, a new report suggests some health tech startups scored a critical infusion of cash just in the nick of time.

Traditional contact tracing procedures in the U.S. are not fast enough for the new coronavirus. But existing digital tools could make them instantaneous.

Opinion: The U.S. is still in the clambering-into-the-life-raft phase of responding to Covid-19, and thinking clearly about what to do next is still difficult.